OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production utilizes Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex biologics. Improving these processes involves fine-tuning various variables, including cell line development, media composition, and bioreactor environments. A key goal is to maximize antibody yield while lowering production cost